A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19
Clinical trial NCT04771000 · TERMINATED
Trial details
- NCT number
- NCT04771000
- Sponsor
- Noorik Biopharmaceuticals AG
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-08
- Primary completion
- 2023-02-27
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.